The growth of the North American nuclear medicine market can be primarily attributed to factors such as increasing incidence and prevalence of cancer and cardiovascular diseases, and initiatives to close the supply-demand gap for Mo-99.
North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, at a CAGR of 4.1%.
Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108
Market Segmentation
Based on type, North American market for Ra-223 is expected to command the largest share owing to its targeted properties over beta emitters and being the only alpha-emitter product available in the market. the market is categorized into diagnostic and therapeutic nuclear medicine.
Based on application, The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.
Based on procedural volume assessment, The F-18 segment is expected to account for the largest share of the PET procedural volume assessment. The large share of this segment can be attributed to the increasing use of F-18 in diagnostic PET applications.
Regional Analysis
The US is expected to account for the largest share and also register the highest CAGR during the forecast period. The growth of this market can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country
Key Market Players
The prominent players in the global North American nuclear medicine market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).
Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108
Key Questions Addressed by the Report
- Which product segment will dominate the North American nuclear medicine market in the future?
- Which application segment will dominate the market in the future?
- Emerging countries offer immense opportunities for the growth and adoption of nuclear medicine; will this scenario continue in the coming five years?
- Where will technology advancements offered by various companies take the industry in the mid- to long-term?
- What are the upcoming products in the nuclear medicine market?